NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

抗肥胖藥的全球市場的預測

Antiobesity Drugs Global Market Report 2020

出版商 The Business Research Company 商品編碼 916220
出版日期 按訂單生產 內容資訊 英文
商品交期: 2-10個工作天內
價格
抗肥胖藥的全球市場的預測 Antiobesity Drugs Global Market Report 2020
出版日期: 按訂單生產內容資訊: 英文
簡介

本報告提供全球抗肥胖藥市場相關調查分析,市場特徵、規模、成長率,區分,各地區、各國明細,競爭情形,市場佔有率,趨勢、策略相關的系統性資訊。

第1章 摘要整理

第2章 抗肥胖藥市場特徵

第3章 抗肥胖藥市場規模、成長率

  • 市場成果 (金額)
  • 市場預測 (金額)

第4章 抗肥胖藥市場區隔

  • 各藥物分類
  • 各類型
  • 各藥物治療

第5章 抗肥胖藥市場各地區、各國分析

  • 各地區
  • 各國

第6章 亞太地區的抗肥胖藥市場

  • 市場概要
  • 各藥物分類
  • 各類型

第7章 中國的抗肥胖藥市場

  • 市場概要
  • 各藥物分類
  • 各類型

第8章 印度的抗肥胖藥市場

  • 市場概要
  • 各藥物分類
  • 各類型

第9章 日本的抗肥胖藥市場

  • 市場概要
  • 各藥物分類
  • 各類型

第10章 澳洲的抗肥胖藥市場

  • 市場概要
  • 各藥物分類
  • 各類型

第11章 印尼的抗肥胖藥市場

  • 市場概要
  • 各藥物分類
  • 各類型

第12章 韓國的抗肥胖藥市場

  • 市場概要
  • 各藥物分類
  • 各類型

第13章 西歐的抗肥胖藥市場

第14章 英國的抗肥胖藥市場

第15章 德國的抗肥胖藥市場

第16章 法國的抗肥胖藥市場

第17章 東歐的抗肥胖藥市場

第18章 俄羅斯的抗肥胖藥市場

第19章 北美的抗肥胖藥市場

第20章 美國的抗肥胖藥市場

第21章 南美的抗肥胖藥市場

第22章 巴西的抗肥胖藥市場

第23章 中東的抗肥胖藥市場

第24章 非洲的抗肥胖藥市場

第25章 抗肥胖藥市場競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline PLC
    • Boehringer Ingelheim GmbH
    • Pfizer Inc.
    • Merck & Co. Inc.

第26章 抗肥胖藥市場主要M&A

第27章 抗肥胖藥市場趨勢與策略

第28章 產品平台分析

第29章 抗肥胖藥市場未來發展預測與可能性分析

第30章 附錄

目錄

Title:
Antiobesity Drugs Global Market Report 2020 - Including: 1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs 2) By Type: Prescription Drugs (Rx), OTC Drugs 3) By Medication: Monotherapies, Polytherapies Covering: F. Hoffmann-La Roche AG,, GlaxoSmithKline PLC,, Boehringer Ingelheim GmbH,, Pfizer Inc.,, Merck & Co. Inc.,.

Antiobesity Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antiobesity drugs market.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antiobesity drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antiobesity Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

  • Markets Covered: 1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs 2) By Type: Prescription Drugs (Rx), OTC Drugs 3) By Medication: Monotherapies, Polytherapies
  • Companies Mentioned: F. Hoffmann-La Roche AG, , GlaxoSmithKline PLC, , Boehringer Ingelheim GmbH, , Pfizer Inc.,, Merck & Co. Inc.,
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Anti-obesity Drugs Market Characteristics

3. Anti-obesity Drugs Market Size And Growth

  • 3.1. Global Anti-obesity Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Anti-obesity Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Anti-obesity Drugs Market Segmentation

  • 4.1. Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Peripherally acting anti obesity drugs
  • Centrally acting anti obesity drugs
  • 4.2. Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Prescription Drugs (Rx)
  • OTC Drugs
  • 4.3. Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Monotherapies
  • Polytherapies

5. Anti-obesity Drugs Market Regional And Country Analysis

  • 5.1. Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Anti-obesity Drugs Market

  • 6.1. Asia-Pacific Anti-obesity Drugs Market Overview
  • 6.2. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Anti-obesity Drugs Market

  • 7.1. China Anti-obesity Drugs Market Overview
  • 7.2. China Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Anti-obesity Drugs Market

  • 8.1. India Anti-obesity Drugs Market Overview
  • 8.2. India Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Anti-obesity Drugs Market

  • 9.1. Japan Anti-obesity Drugs Market Overview
  • 9.2. Japan Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Anti-obesity Drugs Market

  • 10.1. Australia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Anti-obesity Drugs Market

  • 11.1. Indonesia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Anti-obesity Drugs Market

  • 12.1. South Korea Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Anti-obesity Drugs Market

  • 13.1. Western Europe Anti-obesity Drugs Market Overview
  • 13.2. Western Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Anti-obesity Drugs Market

  • 14.1. UK Anti-obesity Drugs Market Overview
  • 14.2. UK Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Anti-obesity Drugs Market

  • 15.1. Germany Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Anti-obesity Drugs Market

  • 16.4. France Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.5. France Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Anti-obesity Drugs Market

  • 17.1. Eastern Europe Anti-obesity Drugs Market Overview
  • 17.2. Eastern Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Anti-obesity Drugs Market

  • 18.1. Russia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Anti-obesity Drugs Market

  • 19.1. North America Anti-obesity Drugs Market Overview
  • 19.2. North America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Anti-obesity Drugs Market

  • 20.1. USA Anti-obesity Drugs Market Overview
  • 20.2. USA Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Anti-obesity Drugs Market

  • 21.1. South America Anti-obesity Drugs Market Overview
  • 21.2. South America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Anti-obesity Drugs Market

  • 22.1. Brazil Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Anti-obesity Drugs Market

  • 23.1. Middle East Anti-obesity Drugs Market Overview
  • 23.2. Middle East Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Anti-obesity Drugs Market

  • 24.1. Africa Anti-obesity Drugs Market Overview
  • 24.2. Africa Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Anti-obesity Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Anti-obesity Drugs Market Competitive Landscape
  • 25.2. Anti-obesity Drugs Market Company Profiles
    • 25.2.1. F. Hoffmann-La Roche AG,
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. GlaxoSmithKline PLC,
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Boehringer Ingelheim GmbH,
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Pfizer Inc.,
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Merck & Co. Inc.,
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anti-obesity Drugs Market

27. Anti-obesity Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Anti-obesity Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer